Millipore Sigma Vibrant Logo

Merck Hosts the First Rx-360 Consortium Global Open Day Meeting

Issue: June 18, 2013
| Category: Regulatory Topics




In our book, the best way to keep counterfeit materials out of the global pharmaceutical supply chain – and hence ensure patient safety – is by building and monitoring a global quality system. That's why in 2009, a global alliance of manufacturers and suppliers called the Rx-360 Consortium was founded.

Last September the Rx-360 Consortium held its very first global open day meeting – and Merck was proud to host the event. At the open day meeting, 125 attendees from 89 organizations came together to assess how far we've come and how best to proceed. Representatives from manufacturers, regulatory agencies (EMA, FDA, EDQM), and suppliers discussed a wide range of topics relating to quality and drug safety, as well as specific regulatory issues.

For Merck and Rx-360, the conference was an important milestone. We look forward to working with our fellow manufacturers and suppliers even more closely in future – for the benefit of patients everywhere.

For more information, please click here

In this same issue:

Recent Articles

Article Search

Article Archives

Events

Webinars